← All news
Markets

BioMarin Pharmaceutical (BMRN)’s Alesta Deal Adds New Growth Potential in Rare Diseases

1 source ·1 article ·Aug 19, 22:02 UTC Biomarin Pharmaceutical

Covered by 1 outlet

All coverage · 1 article